Bartholomäus Regenhardt

Cooley advised Keros Therapeutics (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins, on its exclusive global development and commercialization license agreement with Takeda Pharmaceuticals to advance elritercept.

Cooley advised Sprout Social, a social media management software company, on its $140 million acquisition of Tagger Media, a top influencer marketing platform, and a concurrent $100 million secured debt facility, which will be partially used to fund the acquisition.

A Cooley team advised Horizon Therapeutics, a specialty biopharmaceutical company, on its agreement to be acquired by Amgen. The approximately $28 billion merger would represent the third-largest all-cash transaction in the pharmaceutical sector in history and the biggest healthcare deal of 2022.

Cooley advised Prodege, a cutting-edge marketing and consumer insights platform, on its agreement to acquire BitBurst, a technology-based market research company connecting millions of targeted respondents with surveys every year. Partners Tom Hopkins and Rama Padmanabhan, along with associates Bram Couvreur and Dannielle Antone, led the Cooley team advising Prodege.

Read more

Cooley advised Contentsquare, a global leader in digital experience analytics, on its $400 million Series F financing round. Lawyers Stephane Levy, Tamim Bazzi, Kyle Schwab and Jean Park led the Cooley team advising Contentsquare.